Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

refractory hairy cell leukemia

Known as: Hairy Cell Leukemia, Refractory, leukemia, hairy cell, recurrent, recurrent hairy cell leukemia 
Hairy cell leukemia that is resistant to treatment.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Dear Editor, Hairy cell leukemia (HCL) is a mature B-cell lymphoid cancer that can be treated successfully in the majority of… Expand
  • figure 1
  • figure 2
2013
2013
Purpose: To determine tolerability and for the first time explore efficacy of bendamustine–rituximab (BR) in multiply relapsed… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Highly Cited
2013
Highly Cited
2013
  • R. Hassan, Andrew C. Miller, +8 authors I. Pastan
  • Science Translational Medicine
  • 2013
  • Corpus ID: 206682849
In patients with advanced chemotherapy-refractory mesothelioma, treatment with the anti-mesothelin immunotoxin SS1P and… Expand
2013
2013
Dear Editor, Hairy-cell leukemia (HCL) is a rare hematological malignancy, which typically responds very well to first-line… Expand
  • figure 1
2012
2012
The purine analogs, pentostatin and cladribine, induce high remission rates when used as first-line monotherapy for hairy cell… Expand
  • figure 1
2007
2007
The purine analogs pentostatin and cladribine have revolutionized the treatment of hairy cell leukemia (HCL) with overall… Expand
Review
2006
Review
2006
An increasing number of patients who have hairy cell leukemia (HCL) have persistent disease that requires treatment, despite… Expand
Highly Cited
2003
Highly Cited
2003
The purpose of this study was to investigate the efficacy and safety of the monoclonal antibody, rituximab, in relapsed or… Expand
  • table 1
  • table 2
  • table 4
  • table 3
  • figure 1
Highly Cited
1999
Highly Cited
1999
We report major responses in 4 of 4 patients with hairy cell leukemia (HCL) who have recently been treated on a phase I trial… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
1991
1991
Our experience suggests a potential role of fludarabine phosphate in the management of hairy cell leukemia. On the basis of this… Expand